Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitus

American Journal of Transplantation

Volumn 4, Issue 11, 2004, Pages 1921-1927

  Pirenne, Jacques ^a   Deloose, Koen ^a   Coosemans, Willy ^a   Aerts, Raymond ^a   Van Gelder, Frank ^a   Kuypers, Dirk ^a   Maes, Bart ^a   Verslype, Chris ^a   Yap, Paul ^a   Van Steenbergen, Werner ^a   Roskams, Tania ^a   Mathieu, Chantal ^a   Fevery, Johan ^a   Nevens, Frederik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Diabetes; Liver; Pancreas; Transplantation

Indexed keywords

BASILIXIMAB; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL CANCER; ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; CHOLANGITIS; CHOLESTASIS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 7244248874     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00588.x     Document Type: Article

References (41)

1. Shetty A, Wilson S, Kuo P et al. Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 2000; 69: 2451-2454.
2. Konrad T, Steinmüller T, Vicini P et al. Regulation of glucose tolerance in patients after liver transplantation. Impact of cyclosporin versus tacrolimus therapy. Transplantation 2000; 69: 2072-2078.
3. Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380-384.
4. Boudreaux JP, McHugh L, Canafax DM et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376-381.
5. Haydon G, Neuberger J. Liver transplantation in cirrhotic patients with diabetes mellitus. Liver Transpl 2001; 7: 234-237.
6. Trail KC, McCashland TM, Larsen JL et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 276-283.
7. Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P, Pirenne J. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999; 68: 530-535.
8. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 1007-1012.
9. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995; 180: 1-9.
10. Starzl TE, Todo S, Tzakis A et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989; 210: 374-386.
11. Trotter JF, Bak TE, Wachs ME, Everson GT, Kam I. Combined liver-pancreas transplantation in a patient with primary sclerosing cholangitis and insulin-dependent diabetes mellitus. Transplantation 2000; 70: 1469-1471.
12. Calne RY, Rolles K, White DJ et al. Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 1979; 2: 1033-1036.
13. Mayes JT, Boyle JT, Schulak JA. Simultaneous orthotopic liver and heterotopic pancreas transplantation. Transplantation 1991; 52: 146-147.
14. Trail KC, Stratta RJ, Larsen JL et al. Orthotopic hepatic transplantation in patients with type 1 diabetes mellitus. J Am Coll Surg 1994; 178: 337-342.
15. Stern RC, Mayes JT, Weber FL Jr, Blades EW, Schulak JA. Restoration of exocrine pancreatic function following pancreas-liver-kidney transplantation in a cystic fibrosis patient. Clin Transplant 1994; 8: 1-4.
16. Abu-Elmagd K, Bond G, Reyes J, Fung J. Intestinal transplantation: A coming of age. Adv Surg 2002; 36: 65-101.
17. Thompson HH, Pitt HA, Tompkins RK, Longmire WP Jr. Primary sclerosing cholangitis: A heterogenous disease. Ann Surg 1982; 196: 127-136.
18. Alberti-Flor JJ, Jeffers L, Schiff ER. Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus. Am J Gastroenterol 1984; 79: 889-891.
19. Gluch J, Glaser J. Primär-sklerosierende cholangitis, colitis ulcerosa und diabetes mellitus Typ 1. Z Gastroenterol 1999; 37: 735-738.
20. Kay M, Wyllie R, Michener W, Caulfield M, Steffen R. Associated ulcerative colitis, sclerosing cholangitis and insulin-dependent diabetes mellitus. Cleve Clin J Med 1993; 60: 473-478.
21. James O, Day C. Non-alcoholic steatohepatitis: Another disease of affluence. Lancet 1999; 353: 1634-1636.
22. Day CP. Non-alcoholic steatohepatitis (NASH): Where are we now and where are we going? Gut 2002; 50: 585-588.
23. Garcia RF, Morales E, Garcia CE, Saksena S, Hubscher SG, Elias E. Recurrent and de novo-alcoholic steatohepatitis following orthotopic liver transplantation. Arq Gastroenterol 2001; 38: 247-253.
24. Molloy RM, Komorowski R, Varma RR. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 1997; 3: 177-178.
25. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 115-117.
26. Sollinger HW, Odorico JS, Knechtle SJ, D'Alessandro AM, Kalayoglu M, Pirsch JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998; 228: 284-296.
27. Gaber AO, Shokouh-Amiri H, Hathaway DK et al. Pancreas transplantation with portal venous and enteric drainage eliminates hyperinsulinemia and reduces post-operative complications. Transplant Proc 1993; 35: 1176-1178.
28. Calne RY, Brons JGM. Paratopic pancreas transplantation. In:Groth CG, ed. Pancreatic Transplantation. Philadelphia: Saunders, 1988; 169.
29. Humar A, Khwaja K, Ramcharan T et al. Chronic rejection: The next major challenge for pancreas transplant recipients. Transplantation 2003; 76: 918-923.
30. Calne RY, Sells RA, Pena JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
31. Johnston TD, Ranjan D. Transplantation of the liver combined with other organs. Hepatogastroenterology 1998; 45: 1387-1390.
32. Benedetti E, Pirenne J, Troppmann C et al. Combined liver and kidney transplantation. Transpl Int 1996; 9: 486-491.
33. Wang C, Sun J, Wang L, Li L, Horvat M, Sheil R. Combined liver and pancreas transplantation induces pancreas allograft tolerance. Transplant Proc 1997; 29: 1145-1146.
34. Wang C, Sun J, Li L, Wang L, Dolan P, Sheil AG. Conversion of pancreas allograft rejection to acceptance by liver transplantation. Transplantation 1998; 65: 188-192.
35. Abu-Elmagd K, Reyes J, Bond G et al. Clinical intestinal transplantation: A decade of experience at a single center. Ann Surg 2001; 234: 404-416.
36. Abu-Elmagd K, Reyes J, Todo S et al. Clinical intestinal transplantation: New perspectives and immunological considerations. J Am Coll Surg 1998; 186: 512-525.
37. Pirenne J, Benedetti E, Dunn DL. Graft-versus-host responses. Clinical and biological relevance after transplantation of solid lymphoid organs. Transplant Rev 1996; 10: 46-68.
38. Pirenne J, Nakhleh R, Dunn DL. Graft-versus-host disease after multiorgan transplantation in the rat. J Surg Res 1991; 50: 622-628.
39. Tzakis AG, Ricordi C, Alejandro R et al. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990; 336: 402-405.
40. Ricordi C, Alejandro R, Angelico MC et al. Human islet allografts in patients with type 2 diabetes undergoing liver transplantation. Transplantation 1997; 63: 473-475.
41. Shapiro AM, Lakey JR, Rajotte RV et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 1995; 59: 1060-1063.